Updated:
Eos BioInnovation
EOS Bioinnovation is a venture firm founded in 2022 in Cambridge, Massachusetts. It focuses on regenerative medicine, including therapies and technologies that...
Eos BioInnovation
EOS Bioinnovation is a venture firm founded in 2022 in Cambridge, Massachusetts. It focuses on regenerative medicine, including therapies and technologies that repair, replace, and regenerate organs, tissues, cells, genes, and metabolic processes. The firm has made 4 investments, including a Seed VC investment in TECregen on January 08, 2026.
General information
Firm type
Asset Manager
Year founded
2022
Location
Region
North America
Country
United States
City
Pasadena
Corporate office
Pasadena, CA, United States
Additional offices
Montreal · Boston · Durham · San Francisco · Menlo Park · Cambridge · Baltimore · Toronto · New York · Los Angeles · Chicago
Sector focus
Frequently asked questions
What is Eos BioInnovation's investment model?
Eos BioInnovation operates a translational investment model focused on moving scientific discoveries from university laboratories into commercial ventures. The firm's geographic network of twelve North American offices places local teams adjacent to major research universities in cities like Boston, San Francisco, Montreal, and Durham. This structure enables early engagement with principal investigators and technology transfer offices before formal company formation begins.
What sectors does Eos BioInnovation focus on?
Based on the firm's name and translational model, Eos BioInnovation targets biotech, life sciences, digital health, and agricultural biology. The bio-innovation framing encompasses therapeutics, diagnostics, medical devices, synthetic biology, and computational biology — all areas where university research generates licensable intellectual property. No explicit sector exclusions have been identified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: